//
Percutaneous Coronary Intervention for Chronic Total Occlusion—The Michigan Experience: Insights From the BMC2 Registry
Clinical Efficacy and Safety of Alirocumab after Acute Coronary Syndrome According to Achieved Level of Low-Density Lipoprotein Cholesterol: A Propensity Score-Matched Analysis of the ODYSSEY OUTCOMES Trial
Prognostically relevant periprocedural myocardial injury and infarction associated with percutaneous coronary interventions: a Consensus Document of the ESC Working Group on Cellular Biology of the Heart and European Association of Percutaneous Cardiovascular Interventions (EAPCI)
The Prognostic Significance of Periprocedural Infarction in the Era of Potent Antithrombotic Therapy: The PRAGUE-18 Substudy
Cardiac Shock Care Centers: JACC Review Topic of the Week
Myocardial Infarction Risk Stratification With a Single Measurement of High-Sensitivity Troponin I
Antiplatelet therapy in patients with myocardial infarction without obstructive coronary artery disease
Intravenous Statin Administration During Myocardial Infarction Compared With Oral Post-Infarct Administration